#LSCLC
LightNews LightNews
oncodaily.bsky.social
Ivonescimab vs pembrolizumab in PD-L1 positive NSCLC - Yüksel Ürün
@yukselurun.bsky.social

oncodaily.com/blog/252682

#Cancer #Medicine #Health #CancerResearch #LungCancer #LSCLC #CancerTreatment #Oncology #OncoDaily
Yüksel Ürün: Ivonescimab vs pembrolizumab in PD-L1 positive NSCLC - OncoDaily
Yüksel Ürün: Ivonescimab vs pembrolizumab in PD-L1 positive NSCLC / Anwen Xiong, Baogang Liu, Caicun Zhou, cancer, Jianhua Chen, Jun Yao, Junqiang Chen, Lei
oncodaily.com
March 8, 2025 at 8:04 PM